Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Co. stock logo
MCK
McKesson
$682.41
-4.8%
$631.55
$464.42
$728.32
$85.52B0.49887,462 shs3.08 million shs
Natera, Inc. stock logo
NTRA
Natera
$133.87
-3.5%
$157.48
$83.13
$183.00
$18.10B1.81.38 million shs3.25 million shs
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$120.23
-9.5%
$132.43
$90.03
$171.20
$11.44B1.771.51 million shs2.88 million shs
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$14.99
-9.5%
$20.59
$5.12
$25.29
$1.33B0.841.50 million shs2.86 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$524.94
-2.9%
$509.39
$436.38
$630.73
$480.17B0.624.84 million shs9.91 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$135.28
-5.5%
$146.49
$135.23
$159.64
$35.72B0.718.77 million shs21.34 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Co. stock logo
MCK
McKesson
+3.25%+7.55%+11.34%+24.12%+32.70%
Natera, Inc. stock logo
NTRA
Natera
-3.14%-6.47%-2.56%-17.24%+49.78%
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
-3.18%-1.09%+8.28%+8.39%+28.88%
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
-7.69%-18.70%-15.94%-12.20%+137.25%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+3.30%+4.84%+13.97%+5.43%+17.65%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
-0.81%-1.27%-3.41%+3.00%-0.62%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
McKesson Co. stock logo
MCK
McKesson
4.2947 of 5 stars
2.53.03.33.03.52.51.3
Natera, Inc. stock logo
NTRA
Natera
3.6408 of 5 stars
4.53.00.00.03.52.50.6
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
4.9008 of 5 stars
4.43.00.04.32.72.53.1
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
2.4772 of 5 stars
4.51.00.00.02.60.80.6
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.8552 of 5 stars
3.53.04.24.03.53.31.3
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
McKesson Co. stock logo
MCK
McKesson
2.93
Moderate Buy$661.00-3.14% Downside
Natera, Inc. stock logo
NTRA
Natera
3.00
Buy$178.1233.05% Upside
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
2.89
Moderate Buy$166.4138.41% Upside
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
2.93
Moderate Buy$31.46109.88% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
3.10
Buy$629.3219.88% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
2.77
Moderate Buy$135.27-0.01% Downside

Current Analyst Ratings Breakdown

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2025
McKesson Co. stock logo
MCK
McKesson
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$630.00 ➝ $690.00
4/3/2025
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
4/2/2025
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$642.00 ➝ $745.00
4/1/2025
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $31.00
3/26/2025
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$165.00
3/14/2025
McKesson Co. stock logo
MCK
McKesson
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$641.00 ➝ $691.00
3/13/2025
Natera, Inc. stock logo
NTRA
Natera
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$251.00
3/12/2025
Natera, Inc. stock logo
NTRA
Natera
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Buy
3/5/2025
Natera, Inc. stock logo
NTRA
Natera
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$176.00 ➝ $185.00
3/4/2025
Natera, Inc. stock logo
NTRA
Natera
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$200.00 ➝ $205.00
2/28/2025
Natera, Inc. stock logo
NTRA
Natera
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
McKesson Co. stock logo
MCK
McKesson
$344.58B0.25$37.13 per share18.38($21.58) per share-31.62
Natera, Inc. stock logo
NTRA
Natera
$1.70B10.66N/AN/A$6.37 per share21.02
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$20.67B0.55$18.47 per share6.51$61.19 per share1.96
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$233.18M5.70N/AN/A$2.67 per share5.61
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$400.28B1.20$33.82 per share15.52$106.78 per share4.92
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
McKesson Co. stock logo
MCK
McKesson
$3.00B$21.8431.2518.621.290.82%-181.26%5.34%5/6/2025 (Estimated)
Natera, Inc. stock logo
NTRA
Natera
-$434.80M-$1.53N/AN/AN/A-14.01%-26.23%-14.27%5/8/2025 (Estimated)
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$3.20B$32.233.738.951.0215.48%21.88%3.99%4/29/2025 (Estimated)
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
-$111.40M-$4.10N/AN/AN/A-137.90%-1,636.87%-55.95%5/5/2025 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$14.41B$15.5033.8715.801.373.60%26.69%8.80%4/17/2025 (Estimated)
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A29.15N/AN/AN/AN/AN/A

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$3.10N/AN/AN/A$5.15 billionN/A
4/17/2025N/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.24N/AN/AN/A$111.56 billionN/A
2/27/2025Q4 2024
Natera, Inc. stock logo
NTRA
Natera
-$0.42-$0.41+$0.01-$0.41$447.91 million$476.10 million
2/20/2025Q4 2024
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
-$0.58-$0.73-$0.15-$0.73$72.38 million$74.79 million
2/12/2025Q4 2024
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
$2.95$3.44+$0.49$3.32N/AN/A
2/5/2025Q3 2025
McKesson Co. stock logo
MCK
McKesson
$8.60$8.03-$0.57$6.95$95.86 billionN/A
1/16/2025Q4 24
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.74$6.81+$0.07$5.98$101.60 billion$100.81 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
McKesson Co. stock logo
MCK
McKesson
$2.840.42%+14.33%13.00%17 Years
Natera, Inc. stock logo
NTRA
Natera
N/AN/AN/AN/AN/A
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
N/AN/AN/AN/AN/A
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.401.60%+13.46%54.19%15 Years
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$2.341.73%N/AN/AN/A

Latest NTRA, THC, TVTX, UNH, MCK, and XLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/30/2025
McKesson Co. stock logo
MCK
McKesson
quarterly$0.710.47%3/3/20253/3/20254/1/2025
1/9/2025
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$0.56453/24/20253/24/20253/26/2025
1/9/2025
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$0.56453/24/20253/24/20253/26/2025
2/24/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.101.8%3/10/20253/10/20253/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
McKesson Co. stock logo
MCK
McKesson
N/A
0.88
0.48
Natera, Inc. stock logo
NTRA
Natera
0.33
4.39
4.23
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
2.25
1.78
1.70
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
24.96
1.71
1.68
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.74
0.83
0.91
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
McKesson Co. stock logo
MCK
McKesson
75,000125.33 million125.19 millionOptionable
Natera, Inc. stock logo
NTRA
Natera
3,020135.19 million121.99 millionOptionable
Tenet Healthcare Co. stock logo
THC
Tenet Healthcare
102,40095.12 million94.24 millionOptionable
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
46088.74 million75.12 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000914.71 million917.25 millionOptionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A264.07 millionN/ANot Optionable

Recent News About These Companies

XLV: My Method For Navigating These Pullbacks
Health Care Sector Trying to Bounce Back
Time for Defensive Sector ETFs?
Health Care Has Been a Top Sector
Final Trade: FWONK, XLV, MSFT, PEP

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
McKesson stock logo

McKesson NYSE:MCK

$682.41 -34.52 (-4.82%)
Closing price 03:59 PM Eastern
Extended Trading
$688.74 +6.34 (+0.93%)
As of 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Natera stock logo

Natera NASDAQ:NTRA

$133.87 -4.84 (-3.49%)
Closing price 04:00 PM Eastern
Extended Trading
$131.43 -2.44 (-1.83%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

Tenet Healthcare stock logo

Tenet Healthcare NYSE:THC

$120.23 -12.63 (-9.51%)
As of 03:59 PM Eastern

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Travere Therapeutics stock logo

Travere Therapeutics NASDAQ:TVTX

$14.99 -1.57 (-9.48%)
Closing price 04:00 PM Eastern
Extended Trading
$15.02 +0.03 (+0.20%)
As of 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$524.94 -15.50 (-2.87%)
Closing price 03:59 PM Eastern
Extended Trading
$522.09 -2.85 (-0.54%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Health Care Select Sector SPDR Fund stock logo

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$135.28 -7.85 (-5.48%)
Closing price 04:10 PM Eastern
Extended Trading
$135.10 -0.19 (-0.14%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.